galactose has been researched along with Psoriasis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alberton, V; Bott, C; Cassol, CA; Malvar, A; Nadasdy, GM; Nadasdy, T; Nagaraja, HN; Rovin, BH; Satoskar, AA | 1 |
| Lenler-Petersen, P; Søgård, H; Thestrup-Pedersen, K; Zachariae, H | 1 |
| Alroy, J; Lever, WF; Orfanos, CE; Schaumburg-Lever, G; Ucci, A | 1 |
| Fünfstück, V; Henkel, U; Hipler, C; Knopf, B; Schlesier, F; Wollina, U | 1 |
| Friman, C; Johansson, E; Juvani, M | 1 |
| Hamann, D; Zirwas, M | 1 |
| Lin, Z; Liu, Z; Meng, S; Sun, L; Wang, L; Wang, Z; Xi, L; Zheng, Y | 1 |
| El-Gogary, RI; Elmowafy, E; Nasr, M; Ragai, MH | 1 |
| Abdelbary, AA; AbouGhaly, MH | 1 |
| Bhatia, A; Bhushan, S; Katare, OP; Singh, B | 1 |
| Bernardi, DS; Bortoloto, J; Maciel, NR; Oliveira, GC; Pereira, TA; Rocha-Filho, PA; Viera, GS | 1 |
1 trial(s) available for galactose and Psoriasis
| Article | Year |
|---|---|
Novel antipsoriatic fluidized spanlastic nanovesicles: In vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy.
Topics: Administration, Cutaneous; Adult; Animals; Dermatologic Agents; Eucalyptol; Female; Hexoses; Humans; Male; Middle Aged; Nanostructures; Nicotinic Acids; Polysorbates; Psoriasis; Rats; Skin; Skin Absorption; Treatment Outcome; Young Adult | 2019 |
10 other study(ies) available for galactose and Psoriasis
| Article | Year |
|---|---|
Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Diagnosis, Differential; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Liver Cirrhosis; Lupus Nephritis; Male; Middle Aged; Psoriasis; Retrospective Studies; Staining and Labeling; Young Adult | 2020 |
Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Topics: Administration, Oral; Biopsy; Drug Tolerance; Galactose; Humans; Liver; Liver Cirrhosis; Methotrexate; Psoriasis | 1982 |
Cell surface carbohydrates in psoriasis. Defective cytoplasmic transport by glycoconjugates carrying fucose residues suggested by lectin staining.
Topics: Acetylgalactosamine; Biological Transport; Carbohydrate Metabolism; Cell Membrane; Concanavalin A; Fucose; Galactose; Glucose; Humans; Lectins; Mannose; Plant Lectins; Plants, Toxic; Psoriasis; Ricinus communis; Skin; Staining and Labeling | 1984 |
[Epidermal lectin binding in psoriasis vulgaris. I. Galactosyl glycoconjugates].
Topics: Biopsy; Fluorescent Antibody Technique; Galactose; Glycoconjugates; Humans; Mouth Mucosa; Psoriasis; Receptors, Mitogen; Skin | 1988 |
Transiently increased urinary excretion of low-sulphated heparan sulphate in psoriatic erythroderma associated with benign gammopathy.
Topics: Acute Disease; Chromatography, DEAE-Cellulose; Chromatography, Paper; Dermatitis, Exfoliative; Electrophoresis, Paper; Galactosamine; Galactose; Glucosamine; Glycosaminoglycans; Heparitin Sulfate; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Psoriasis; Quaternary Ammonium Compounds; Skin; Sulfuric Acids; Testis; Time Factors; Ultrafiltration; Uronic Acids | 1974 |
Successful patch testing of a patient receiving anti-interleukin-17 therapy with secukinumab: a case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatitis, Allergic Contact; Dermatologic Agents; Hexoses; Humans; Male; Patch Tests; Psoriasis | 2017 |
Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Biomarkers; Cholesterol; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Female; Hexoses; Imiquimod; Interferon Inducers; Interleukins; Liposomes; Mice; Mice, Inbred C57BL; Pentacyclic Triterpenes; Plant Extracts; Psoriasis; Skin; Spleen; Tripterygium; Triterpenes | 2019 |
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Topics: Administration, Cutaneous; Animals; Area Under Curve; Chemistry, Pharmaceutical; Cholesterol; Dermatologic Agents; Drug Carriers; Hexoses; Liposomes; Male; Methotrexate; Microscopy, Electron, Transmission; Models, Statistical; Nanotechnology; Organophosphates; Particle Size; Psoriasis; Rats, Wistar; Skin; Skin Absorption; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2015 |
Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.
Topics: Administration, Cutaneous; Cell Line; Cell Proliferation; Cell Survival; Cholesterol; Drug Carriers; Hexoses; Humans; Inhibitory Concentration 50; Keratinocytes; Liposomes; Membrane Fluidity; Phosphatidylcholines; Psoriasis; Selective Estrogen Receptor Modulators; Surface-Active Agents; Tamoxifen | 2010 |
Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments.
Topics: Administration, Topical; Adult; Antioxidants; Castor Oil; Chemistry, Pharmaceutical; Drug Stability; Electric Conductivity; Emulsions; Female; Hexoses; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nanotechnology; Particle Size; Plant Oils; Psoriasis; Rice Bran Oil; Skin; Skin Absorption; Water; Young Adult | 2011 |